Kiora Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPRX and other ETFs, options, and stocks.About KPRX
Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102.
CEOBrian Matthew Strem
CEOBrian Matthew Strem
Employees12
Employees12
HeadquartersEncinitas, California
HeadquartersEncinitas, California
Founded1998
Founded1998
Employees12
Employees12
KPRX Key Statistics
Market cap9.47M
Market cap9.47M
Price-Earnings ratio-0.95
Price-Earnings ratio-0.95
Dividend yield—
Dividend yield—
Average volume11.88K
Average volume11.88K
High today$3.21
High today$3.21
Low today$3.11
Low today$3.11
Open price$3.13
Open price$3.13
Volume4.91K
Volume4.91K
52 Week high$5.55
52 Week high$5.55
52 Week low$2.51
52 Week low$2.51
People also own
Based on the portfolios of people who own KPRX. This list is generated using Robinhood data, and it’s not a recommendation.